Federico Grossi

Federico Grossi

Company: Apellis Pharmaceuticals

Job title: Chief Medical Officer

Seminars:

Panel Discussion – The Current Landscape of Dry AMD Therapeutics 8:00 am

Reviewing complement inhibition as a means of treating dry AMD Outlining the promise of small molecule, cell therapy, stem cell therapy and gene therapy What is the earliest stage of AMD feasible for a clinical trial?Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.